Publinova logo
product

Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies



Publication date

Type

Document

Right Of Use
copyright.yescopyright.yescopyright.yescopyright.yes
Access Rights

OpenAccess

DOI

Not known